title: IMWG consensus on risk stratification in multiple myeloma.
abstract: Multiple myeloma is characterized by underlying clinical and biological heterogeneity, which translates to variable response to treatment and outcome. With the recent increase in treatment armamentarium and the projected further increase in approved therapeutic agents in the coming years, the issue of having some mechanism to dissect this heterogeneity and rationally apply treatment is coming to the fore. A number of robustly validated prognostic markers have been identified and the use of these markers in stratifying patients into different risk groups has been proposed. In this consensus statement, the International Myeloma Working Group propose well-defined and easily applicable risk categories based on current available information and suggests the use of this set of prognostic factors as gold standards in all clinical trials and form the basis of subsequent development of more complex prognostic system or better prognostic factors. At the same time, these risk categories serve as a framework to rationalize the use of therapies.
authors: 1] Department of Haematology Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore [2] Experimental Therapeutics, Cancer Science Institute of Singapore, Singapore, Singapore [3] Department of Medicine, Yoo Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
authors: W J
authors: WJ
authors: Chng
authors: Division of Hematology, Mayo Clinic, Rochester, MN, USA.
authors: A
authors: A
authors: Dispenzieri
authors: Division of Hematology and Medical Oncology, Queen Mary Hospital, Hong, Kong.
authors: C-S
authors: CS
authors: Chim
authors: Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA.
authors: R
authors: R
authors: Fonseca
authors: University of Heidelberg, Heidelberg, Germany.
authors: H
authors: H
authors: Goldschmidt
authors: Department of Medicine, Hematology/Oncology, Columbia University, NY, USA.
authors: S
authors: S
authors: Lentzsch
authors: Dana- Farber Cancer Institute, Boston, MA, USA.
authors: N
authors: N
authors: Munshi
authors: Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy.
authors: A
authors: A
authors: Palumbo
authors: Servicio de Hematologia, Hospital Universitario de Salamanca, CIC, IBMCC (USAL-CSIC), Salamanca, Spain.
authors: J S
authors: JS
authors: Miguel
authors: Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors: P
authors: P
authors: Sonneveld
authors: Institute of Hematology and Medical Oncology "Seragnoli", Bologna University School of Medicine, Bologna, Italy.
authors: M
authors: M
authors: Cavo
authors: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors: S
authors: S
authors: Usmani
authors: Southwest Oncology Group, International Myeloma Foundation, Cedars- Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer, Institute, Los Angeles, CA, USA.
authors: B G M
authors: BG
authors: Durie
authors: Unité de Génomique du Myélome, University Hospital, Toulouse, France.
authors: H
authors: H
authors: Avet-Loiseau
mesh_terms: D003245:Consensus Statements as Topic; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy*; D011379:Prognosis
references: Blood. 2008 Feb 1;111(3):1603-9
references: 18006703
references: Blood. 2012 Jan 5;119(1):7-15
references: 22021371
references: Bone Marrow Transplant. 2008 Sep;42(6):413-20
references: 18587435
references: Haematologica. 2011 Apr;96(4):574-82
references: 21173094
references: Haematologica. 2010 Jul;95(7):1150-7
references: 20220069
references: Mayo Clin Proc. 2009 Dec;84(12):1095-110
references: 19955246
references: Clin Cancer Res. 2011 Dec 1;17(23):7240-7
references: 21986844
references: Blood. 2009 Dec 24;114(27):5436-43
references: 19861683
references: Blood. 2003 Jun 1;101(11):4569-75
references: 12576322
references: PLoS One. 2013 Jun 20;8(6):e66361
references: 23840451
references: Leukemia. 2009 Dec;23(12):2210-21
references: 19798094
references: Leukemia. 2010 Apr;24(4):833-42
references: 20220778
references: Haematologica. 2012 Nov;97(11):1757-60
references: 22689673
references: J Clin Oncol. 2005 May 20;23(15):3412-20
references: 15809451
references: Cancer Cell. 2007 Aug;12(2):131-44
references: 17692805
references: Blood. 2008 Mar 1;111(5):2516-20
references: 17975015
references: Leukemia. 2014 Mar;28(3):675-9
references: 23892719
references: Leukemia. 2012 Nov;26(11):2406-13
references: 22722715
references: Biol Blood Marrow Transplant. 2013 Mar;19(3):398-404
references: 23078786
references: J Clin Oncol. 2012 Jun 1;30(16):1949-52
references: 22547600
references: Best Pract Res Clin Haematol. 2007 Dec;20(4):625-35
references: 18070710
references: Cancer. 2008 Jul 15;113(2):355-9
references: 18470907
references: Blood. 1998 Apr 1;91(7):2501-7
references: 9516151
references: Blood. 2012 Jan 26;119(4):940-8
references: 22160383
references: Lancet. 2010 Dec 18;376(9758):2075-85
references: 21146205
references: Blood. 2005 Oct 1;106(7):2276-9
references: 15961515
references: Leukemia. 2012 Feb;26(2):349-55
references: 21836613
references: J Clin Oncol. 2010 Oct 20;28(30):4630-4
references: 20644101
references: N Engl J Med. 2008 Aug 28;359(9):906-17
references: 18753647
references: Blood. 2012 Aug 2;120(5):1060-6
references: 22529291
references: J Clin Oncol. 2010 Mar 20;28(9):1599-605
references: 20177027
references: Blood. 2007 Apr 15;109(8):3489-95
references: 17209057
references: Blood. 2011 Oct 27;118(17):4519-29
references: 21841166
references: Nat Rev Clin Oncol. 2011 Apr 26;8(8):479-91
references: 21522124
references: Blood. 2009 Aug 13;114(7):1299-305
references: 19515721
references: Blood. 2011 Mar 17;117(11):3025-31
references: 21228328
references: Leukemia. 2013 Mar;27(3):711-7
references: 23032723
references: Blood. 2008 Nov 15;112(10):4017-23
references: 18669875
references: Clin Cancer Res. 2007 Dec 1;13(23):7073-9
references: 18056185
references: Blood. 2011 Nov 3;118(18):4771-9
references: 21860026
references: Blood. 2011 Sep 22;118(12):3205-11
references: 21791430
references: J Clin Oncol. 2009 Dec 1;27(34):5720-6
references: 19826130
references: Blood. 1993 Jun 15;81(12):3382-7
references: 8507875
references: Clin Cancer Res. 2011 Dec 15;17(24):7776-84
references: 21994415
references: Blood. 2007 Mar 15;109(6):2276-84
references: 17105813
references: Blood. 2011 Mar 17;117(11):3041-4
references: 21098740
references: Nat Biotechnol. 2010 Aug;28(8):827-38
references: 20676074
references: Blood. 2011 May 5;117(18):4696-700
references: 21292777
references: Blood. 2012 Jan 19;119(3):687-91
references: 22128143
references: Blood. 2012 Aug 2;120(5):1067-76
references: 22498740
references: J Clin Oncol. 2010 Apr 20;28(12):2077-84
references: 20308672
references: Cancer. 1975 Sep;36(3):842-54
references: 1182674
references: Nature. 2011 Mar 24;471(7339):467-72
references: 21430775
references: J Clin Oncol. 2012 Aug 20;30(24):2946-55
references: 22802322
references: Br J Haematol. 2009 Nov;147(3):347-51
references: 19702643
references: J Clin Oncol. 2008 Dec 10;26(35):5775-82
references: 19001321
references: Leukemia. 2006 Nov;20(11):2034-40
references: 17024118
references: Clin Cancer Res. 2010 Mar 15;16(6):1856-64
references: 20215539
references: Blood. 2006 Sep 1;108(5):1724-32
references: 16705089
references: Blood. 2012 Mar 1;119(9):2100-5
references: 22234687
references: Blood. 2011 Feb 10;117(6):2009-11
references: 20962323
references: Haematologica. 2013 Jan;98(1):71-8
references: 22733020
references: J Clin Oncol. 2008 Oct 10;26(29):4798-805
references: 18591550
references: Leukemia. 2007 Sep;21(9):2020-4
references: 17625611
references: Haematologica. 2011 Jan;96(1):87-95
references: 20884712
references: Blood. 2011 Dec 1;118(23):5989-95
references: 21900189